首页> 美国卫生研究院文献>World Journal of Gastrointestinal Oncology >Role of self expandable stents in management of colorectal cancers
【2h】

Role of self expandable stents in management of colorectal cancers

机译:自扩张支架在结直肠癌治疗中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute malignant colorectal obstruction is a complication of colorectal cancer that can occur in 7%-29% of patients. Self-expanding metallic stent placement for malignant colorectal obstruction has gained popularity as a safe and effective procedure for relieving obstruction. This technique can be used in the palliation of malignant colorectal obstruction, as a bridge to elective surgery for resectable colorectal cancers, palliation of extracolonic malignant obstruction, and for nonmalignant etiologies such as anastomotic strictures, Crohn’s disease, radiation therapy, and diverticular diseases. Self-expanding metallic stent has its own advantages and disadvantages over the surgery in these indications. During the insertion of the self-expanding metallic stent, and in the follow-up, short term and long term morbidities should be kept in mind. The most important complications of the stents are perforation, stent obstruction, stent migration, and bleeding. Additionally, given the high risk of perforation, if a patient is treated or being considered fortreatmentwith antiangiogenic agents such as bevacizumab, it is not recommended to use self-expanding metallic stent as a palliative treatment for obstruction. Therefore, there is a need for careful clinical evaluation for each patient who is a candidate for this procedure. The purpose of this review was to evaluate self-expanding metallic stent in the management of the obstruction of the colon due to the colorectal and extracolonic obstruction.
机译:急性恶性大肠梗阻是大肠癌的一种并发症,可发生于7%-29%的患者中。自膨胀金属支架置入恶性结直肠梗阻已成为一种安全有效的缓解梗阻方法。该技术可用于缓解结直肠癌的恶性梗阻,为可切除结直肠癌的选择性手术,结肠外恶性肿瘤梗阻的姑息外科手术以及吻合口狭窄,克罗恩病,放射疗法和憩室病等非恶性病因提供桥梁。在这些适应症中,自扩张金属支架与手术相比有其自身的优缺点。在插入自膨式金属支架期间,以及在随访期间,应牢记短期和长期发病率。支架最重要的并发症是穿孔,支架阻塞,支架迁移和出血。此外,鉴于穿孔的高风险,如果使用抗血管生成剂(如贝伐单抗)对患者进行治疗或考虑对其进行治疗,则不建议使用自膨式金属支架作为姑息性阻塞治疗。因此,需要对每个候选者进行仔细的临床评估。这篇综述的目的是评估由于结肠直肠和结肠外阻塞引起的结肠阻塞的自膨胀金属支架治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号